Traws Pharma, Inc.

TRAW · NASDAQ
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$1$82-$123-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$5$1-$5-$1
Other Non-Cash-$0-$87$118$0
Operating Cash Flow-$6-$4-$10-$4
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0-$4$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$4$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$7$20$14$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$3$0$0$0
Financing Cash Flow$3$20$14$0
Forex Effect$0-$0-$0$0
Net Chg. in Cash-$3$16$0-$4
Supplemental Information
Beg. Cash$16$5$16$25
End Cash$13$21$17$21
Free Cash Flow-$6-$4-$10-$4